Michael Cohen New CEO of MetriGenix; Heidi Bullock Leaves Vitra Biosciences; Naveen Kulkarni Goes to Polyclone from SysArris; Ren Bernards Wins Spinoza Prize, Claire Fraser Receives Promega Biotech Research Award; and Others | GenomeWeb

Michael Cohen has become the new chief scientific officer of Toronto-based MetriGenix, following the acquisition of GeneXP Biosciences by MetriGenix,. He is the former president of GeneXP.


 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.